From: Right- and left-sided colorectal cancers respond differently to cetuximab
Response | RSCC | LSCRC | ||
---|---|---|---|---|
Chemotherapy alone group | Cetuximab group | Chemotherapy alone group | Cetuximab group | |
Total | 44 | 28 | 49 | 68 |
Best ORR | 5 (11.4) | 2 (7.1) | 5 (10.2) | 16 (23.5) |
CR | 0 (0) | 0 (0) | 0 (0) | 1 (1.4) |
PR | 5 (11.4) | 2 (7.1) | 5 (10.2) | 15 (22.1) |
SD | 21 (47.7) | 16 (57.2) | 23 (46.9) | 34 (50.0) |
PD | 16 (36.4) | 10 (35.7) | 19 (38.8) | 17 (25.0) |
NA | 2 (4.5) | 0 (0) | 2 (4.1) | 1 (1.5) |
P value a | 0.698 | 0.087 |